Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

The completion of the funding round follows Newronika’s recent receival of an IDE from the FDA for the Parkinson’s therapy ...

Prolacta Bioscience, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill and premature infants, announced today that the journal Foods has published ...

Other recent soundings have confirmed that Trump’s general approval rating is higher now than it was eight years ago — ...

In the early hours of September 14, 2021, three men parked in a quiet car park in the southern English market town of ...

Each method has its pros and cons, and the best choice depends on the time and money you’re willing to invest and how ...

Erectile dysfunction (ED) is a common issue that affects millions of men, leading to a decline in quality of life and ...

The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...

Without the once infinite resources and machinery he had at his disposal, will Rodrigo Duterte’s popularity be enough to win ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...